NASDAQ:BRKR - Bruker Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$31.03 +0.53 (+1.74 %)
(As of 05/20/2018 07:39 AM ET)
Previous Close$31.03
Today's Range$30.49 - $31.12
52-Week Range$26.00 - $36.53
Volume364,776 shs
Average Volume663,059 shs
Market Capitalization$4.84 billion
P/E Ratio25.64
Dividend Yield0.52%
Beta1.14

About Bruker (NASDAQ:BRKR)

Bruker logoBruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Debt-to-Equity Ratio0.26
Current Ratio2.22
Quick Ratio1.29

Price-To-Earnings

Trailing P/E Ratio25.64
Forward P/E Ratio22.32
P/E Growth2.04

Sales & Book Value

Annual Sales$1.77 billion
Price / Sales2.74
Cash Flow$1.6479 per share
Price / Cash18.83
Book Value$5.06 per share
Price / Book6.13

Profitability

EPS (Most Recent Fiscal Year)$1.21
Net Income$78.60 million
Net Margins4.63%
Return on Equity27.04%
Return on Assets10.69%

Miscellaneous

Employees6,200
Outstanding Shares156,080,000

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Tuesday, May 15th. Shareholders of record on Monday, June 4th will be given a dividend of $0.04 per share on Friday, June 22nd. This represents a $0.16 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend is Friday, June 1st. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker announced that its Board of Directors has approved a stock repurchase plan on Sunday, June 4th 2017, which permits the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its stock is undervalued.

How were Bruker's earnings last quarter?

Bruker (NASDAQ:BRKR) announced its quarterly earnings results on Thursday, May, 3rd. The medical research company reported $0.24 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.22 by $0.02. The medical research company earned $431.70 million during the quarter, compared to analysts' expectations of $419.25 million. Bruker had a net margin of 4.63% and a return on equity of 27.04%. The company's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.19 earnings per share. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Bruker.

What price target have analysts set for BRKR?

11 brokerages have issued 12-month price objectives for Bruker's shares. Their forecasts range from $24.00 to $42.00. On average, they expect Bruker's share price to reach $32.80 in the next twelve months. View Analyst Ratings for Bruker.

Who are some of Bruker's key competitors?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)
  • Dr. Mark R. Munch Ph.D., Exec. VP, Pres of Bruker Nano Surfaces Division and Pres of Bruker Nano Group (Age 56)
  • Mr. Juergen Srega, Pres of Bruker Daltonics Division and Pres of Bruker CALID Group (Age 63)
  • Mr. Anthony L. Mattacchione, Former CFO & Sr. VP (Age 55)
  • Mr. Gerald N. Herman, VP, Interim CFO and Principal Accounting Officer & Corp. Controller

Has Bruker been receiving favorable news coverage?

Media headlines about BRKR stock have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bruker earned a coverage optimism score of 0.08 on Accern's scale. They also assigned news stories about the medical research company an impact score of 45.65 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Bruker's major shareholders?

Bruker's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.37%), Russell Investments Group Ltd. (0.95%), Victory Capital Management Inc. (0.88%), Boston Partners (0.83%), Millennium Management LLC (0.71%) and Dimensional Fund Advisors LP (0.61%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Mark Munch, Richard A Packer and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which major investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Sensato Investors LLC, Victory Capital Management Inc., New York State Common Retirement Fund, Massachusetts Financial Services Co. MA, Hsbc Holdings PLC, Citadel Advisors LLC and Teacher Retirement System of Texas. Company insiders that have sold Bruker company stock in the last year include Ingen Chris Van, Mark Munch and Richard Kniss. View Insider Buying and Selling for Bruker.

Which major investors are buying Bruker stock?

BRKR stock was purchased by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Point72 Asset Management L.P., Old Mutual Global Investors UK Ltd., Carillon Tower Advisers Inc., Great Lakes Advisors LLC, BlackRock Inc., GSA Capital Partners LLP and Virginia Retirement Systems ET AL. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $31.03.

How big of a company is Bruker?

Bruker has a market capitalization of $4.84 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (BRKR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  445 (Vote Outperform)
Underperform Votes:  506 (Vote Underperform)
Total Votes:  951
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bruker (NASDAQ:BRKR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Bruker in the last 12 months. Their average twelve-month price target is $32.80, suggesting that the stock has a possible upside of 5.70%. The high price target for BRKR is $42.00 and the low price target for BRKR is $24.00. There are currently 2 sell ratings, 8 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.912.072.072.07
Ratings Breakdown: 2 Sell Rating(s)
8 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
10 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.80$32.00$32.0833$28.90
Price Target Upside: 5.70% upside7.24% upside6.10% upside13.32% downside

Bruker (NASDAQ:BRKR) Consensus Price Target History

Price Target History for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2018BTIG ResearchSet Price TargetBuy$42.00LowView Rating Details
5/4/2018Bank of AmericaLower Price TargetNeutral ➝ Neutral$37.00 ➝ $34.00N/AView Rating Details
4/11/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$32.00 ➝ $31.00LowView Rating Details
2/9/2018Leerink SwannBoost Price TargetMarket Perform ➝ Market Perform$32.00 ➝ $34.00HighView Rating Details
1/3/2018Evercore ISIInitiated CoverageIn-Line$36.00LowView Rating Details
12/21/2017CowenReiterated RatingHold$35.00LowView Rating Details
11/3/2017CitigroupBoost Price TargetNeutral$29.00 ➝ $34.00N/AView Rating Details
11/3/2017JPMorgan ChaseUpgradeUnderweight ➝ Neutral$28.00N/AView Rating Details
9/26/2017Goldman SachsReiterated RatingSell ➝ Sell$24.00LowView Rating Details
7/17/2017BarclaysReiterated RatingEqual Weight$26.00 ➝ $30.00LowView Rating Details
7/12/2017Wells FargoDowngradeMarket Perform ➝ UnderperformMediumView Rating Details
5/15/2017Jefferies GroupReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche BankBoost Price TargetHold$25.00 ➝ $27.00N/AView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral ➝ BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLowView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
8/4/2016UBSReiterated RatingHold$27.00N/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 ➝ $23.00N/AView Rating Details
(Data available from 5/20/2016 forward)

Earnings

Bruker (NASDAQ:BRKR) Earnings History and Estimates Chart

Earnings by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Earnings Estimates

2018 EPS Consensus Estimate: $1.33
2019 EPS Consensus Estimate: $1.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.22$0.30$0.25
Q2 20183$0.26$0.32$0.28
Q3 20183$0.32$0.34$0.33
Q4 20183$0.40$0.56$0.47
Q1 20191$0.26$0.26$0.26
Q2 20192$0.28$0.31$0.30
Q3 20192$0.34$0.36$0.35
Q4 20192$0.56$0.60$0.58

Bruker (NASDAQ BRKR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018$0.26N/AView Earnings Details
5/3/2018Q1 2018$0.22$0.24$419.25 million$431.70 millionViewN/AView Earnings Details
2/8/2018Q4 2017$0.49$0.51$506.74 million$530.50 millionViewListenView Earnings Details
11/2/2017Q3 2017$0.27$0.29$415.45 million$435.60 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.20$0.23$384.75 million$414.90 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.1870$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
10/28/2010Q3 2010$0.12$0.19ViewN/AView Earnings Details
7/28/2010Q2 2010$0.12$0.15ViewN/AView Earnings Details
4/29/2010Q1 2010$0.08$0.10ViewN/AView Earnings Details
2/25/2010Q4 2009$0.20$0.27ViewN/AView Earnings Details
10/29/2009Q3 2009$0.07$0.10ViewN/AView Earnings Details
7/29/2009Q2 2009$0.07$0.08ViewN/AView Earnings Details
4/30/2009Q1 2009$0.05$0.05ViewN/AView Earnings Details
3/3/2009Q4 2008$0.12$0.18ViewN/AView Earnings Details
10/30/2008Q3 2008$0.12$0.11ViewN/AView Earnings Details
7/31/2008Q2 2008$0.09$0.13ViewN/AView Earnings Details
5/5/2008Q1 2008$0.06$0.05ViewN/AView Earnings Details
3/17/2008Q4 2007$0.11$0.26ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Bruker (NASDAQ:BRKR) Dividend Information

Bruker pays an annual dividend of $0.16 per share, with a dividend yield of 0.52%. BRKR's next quarterly dividend payment will be made on Friday, June 22. Bruker pays out 13.22% of its earnings out as a dividend.
Next Dividend:6/22/2018
Annual Dividend:$0.16
Dividend Yield:0.52%
Payout Ratio(s):13.22% (Trailing 12 Months of Earnings)
11.51% (Based on This Year's Estimates)
10.39% (Based on Next Year's Estimates)
9.71% (Based on Cash Flow)
Dividend Payments by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2018quarterly$0.040.54%6/1/20186/4/20186/22/2018
2/20/2018Quarterly$0.040.51%3/5/20183/6/20183/23/2018
11/13/2017quarterly$0.040.49%12/1/201712/4/201712/22/2017
8/14/2017quarterly$0.040.57%8/31/20179/5/20179/22/2017
5/15/2017quarterly$0.040.61%6/1/20176/5/20176/23/2017
2/21/2017quarterly$0.040.65%3/6/20173/8/20173/24/2017
11/15/2016quarterly$0.040.69%12/1/201612/5/201612/23/2016
8/9/2016quarterly$0.040.72%9/1/20169/6/20169/23/2016
5/18/2016quarterly$0.040.61%6/2/20166/6/20166/24/2016
2/22/2016Quarterly$0.043/2/20163/4/20163/24/2016
(Data available from 1/1/2013 forward)

Insider Trades

Bruker (NASDAQ BRKR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 35.20%
Institutional Ownership Percentage: 65.88%
Insider Trading History for Bruker (NASDAQ:BRKR)
Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ BRKR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2017Mark MunchVPSell21,061$29.97$631,198.1760,524View SEC Filing  
8/10/2017Frank H LaukienCEOBuy2,335$27.39$63,955.6537,791,386View SEC Filing  
6/14/2017Ingen Chris VanDirectorSell19,900$28.03$557,797.0014,577View SEC Filing  
6/13/2017Richard KnissDirectorSell24,000$28.23$677,520.0046,753View SEC Filing  
6/8/2017Mark MunchVPSell73,724$27.62$2,036,256.88106,602View SEC Filing  
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.0037,789,051View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.0037,750,851View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.6037,712,851View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.0037,710,931View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.0037,706,631View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.5037,704,331View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.005,000View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.6037,699,606View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.0022,500View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.0037,658,733View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.3037,654,233View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.0015,208,795View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.003,000View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bruker (NASDAQ BRKR) News Headlines

Source:
DateHeadline
Bruker (BRKR) Upgraded at Zacks Investment ResearchBruker (BRKR) Upgraded at Zacks Investment Research
www.americanbankingnews.com - May 18 at 4:44 PM
Bruker (BRKR) Rating Lowered to Hold at Zacks Investment ResearchBruker (BRKR) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - May 17 at 10:36 AM
Bruker Plans Quarterly Dividend of $0.04 (BRKR)Bruker Plans Quarterly Dividend of $0.04 (BRKR)
www.americanbankingnews.com - May 15 at 5:18 PM
Bruker (BRKR) Raised to "Buy" at Zacks Investment ResearchBruker (BRKR) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 8 at 3:23 PM
Bruker (BRKR) Expected to Post Quarterly Sales of $443.75 MillionBruker (BRKR) Expected to Post Quarterly Sales of $443.75 Million
www.americanbankingnews.com - May 8 at 2:08 AM
BTIG Research Analysts Give Bruker (BRKR) a $42.00 Price TargetBTIG Research Analysts Give Bruker (BRKR) a $42.00 Price Target
www.americanbankingnews.com - May 7 at 2:57 PM
Research Analysts Set Expectations for Brukers FY2018 Earnings (BRKR)Research Analysts Set Expectations for Bruker's FY2018 Earnings (BRKR)
www.americanbankingnews.com - May 7 at 4:04 AM
Bruker (BRKR) Expected to Announce Earnings of $0.26 Per ShareBruker (BRKR) Expected to Announce Earnings of $0.26 Per Share
www.americanbankingnews.com - May 6 at 8:05 PM
Bruker (BRKR) Price Target Cut to $34.00 by Analysts at Bank of AmericaBruker (BRKR) Price Target Cut to $34.00 by Analysts at Bank of America
www.americanbankingnews.com - May 4 at 7:17 PM
Bruker (BRKR) Q1 2018 Results - Earnings Call TranscriptBruker (BRKR) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 8:03 AM
Edited Transcript of BRKR earnings conference call or presentation 3-May-18 8:30pm GMTEdited Transcript of BRKR earnings conference call or presentation 3-May-18 8:30pm GMT
finance.yahoo.com - May 4 at 8:03 AM
Bruker Corporation to Present at the 43rd Annual Deutsche Bank Health Care ConferenceBruker Corporation to Present at the 43rd Annual Deutsche Bank Health Care Conference
finance.yahoo.com - May 4 at 8:03 AM
Bruker (BRKR) Announces Quarterly  Earnings ResultsBruker (BRKR) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 3 at 9:38 PM
Bruker beats by $0.02, beats on revenueBruker beats by $0.02, beats on revenue
seekingalpha.com - May 3 at 5:39 PM
Bruker: 1Q Earnings SnapshotBruker: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 5:39 PM
Bruker Reports First Quarter 2018 Financial ResultsBruker Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 5:39 PM
Bruker Introduces New NMR Technologies and Research ProductsBruker Introduces New NMR Technologies and Research Products
finance.yahoo.com - April 30 at 9:11 AM
Bruker (BRKR) Given Average Recommendation of "Hold" by AnalystsBruker (BRKR) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 29 at 9:30 PM
BidaskClub Lowers Bruker (BRKR) to HoldBidaskClub Lowers Bruker (BRKR) to Hold
www.americanbankingnews.com - April 27 at 12:13 PM
pSivida (EYPT) vs. Bruker (BRKR) Critical ReviewpSivida (EYPT) vs. Bruker (BRKR) Critical Review
www.americanbankingnews.com - April 26 at 9:04 AM
Bruker Appoints Falko Busse as President of the Bruker BioSpin GroupBruker Appoints Falko Busse as President of the Bruker BioSpin Group
finance.yahoo.com - April 26 at 8:01 AM
Bruker (BRKR) Scheduled to Post Earnings on ThursdayBruker (BRKR) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 26 at 1:20 AM
Bruker Introduces Contour LS-K 3D Optical ProfilerBruker Introduces Contour LS-K 3D Optical Profiler
finance.yahoo.com - April 24 at 8:02 AM
Zacks: Analysts Expect Bruker (BRKR) Will Announce Quarterly Sales of $416.38 MillionZacks: Analysts Expect Bruker (BRKR) Will Announce Quarterly Sales of $416.38 Million
www.americanbankingnews.com - April 21 at 2:16 AM
Bruker introduces new workflow-enhancing solutions for microbial identification and antibiotic resistance testingBruker introduces new workflow-enhancing solutions for microbial identification and antibiotic resistance testing
seekingalpha.com - April 20 at 5:36 PM
Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species CoverageBruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage
finance.yahoo.com - April 20 at 5:36 PM
$0.22 EPS Expected for Bruker (BRKR) This Quarter$0.22 EPS Expected for Bruker (BRKR) This Quarter
www.americanbankingnews.com - April 19 at 7:20 PM
Bruker Announces Date and Time of First Quarter 2018 Earnings Release and WebcastBruker Announces Date and Time of First Quarter 2018 Earnings Release and Webcast
finance.yahoo.com - April 19 at 5:56 PM
Bruker Acquires nanoIR Company Anasys InstrumentsBruker Acquires nanoIR Company Anasys Instruments
finance.yahoo.com - April 17 at 6:13 PM
Bruker (BRKR) Stock Rating Lowered by BidaskClubBruker (BRKR) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 11 at 10:10 PM
Morgan Stanley Trims Bruker (BRKR) Target Price to $31.00Morgan Stanley Trims Bruker (BRKR) Target Price to $31.00
www.americanbankingnews.com - April 11 at 9:23 AM
Bruker introduces the new CTX portable XRF analyzerBruker introduces the new CTX portable XRF analyzer
seekingalpha.com - April 10 at 8:04 AM
Bruker Introduces the New CTX™ Portable XRF AnalyzerBruker Introduces the New CTX™ Portable XRF Analyzer
finance.yahoo.com - April 10 at 8:04 AM
Bruker Launches New FT-IR R&D Spectrometer INVENIO™Bruker Launches New FT-IR R&D Spectrometer INVENIO™
finance.yahoo.com - April 10 at 8:04 AM
Coherent (COHR) & Bruker (BRKR) Head-To-Head SurveyCoherent (COHR) & Bruker (BRKR) Head-To-Head Survey
www.americanbankingnews.com - April 10 at 5:15 AM
BidaskClub Upgrades Bruker (BRKR) to "Buy"BidaskClub Upgrades Bruker (BRKR) to "Buy"
www.americanbankingnews.com - April 6 at 11:17 AM
Bruker (BRKR) Receives Average Rating of "Hold" from AnalystsBruker (BRKR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 4 at 9:34 PM
$419.95 Million in Sales Expected for Bruker (BRKR) This Quarter$419.95 Million in Sales Expected for Bruker (BRKR) This Quarter
www.americanbankingnews.com - April 4 at 2:12 AM
Zacks: Brokerages Anticipate Bruker Co. (BRKR) Will Post Earnings of $0.23 Per ShareZacks: Brokerages Anticipate Bruker Co. (BRKR) Will Post Earnings of $0.23 Per Share
www.americanbankingnews.com - April 2 at 9:16 PM
Analyzing Waters (WAT) & Bruker (BRKR)Analyzing Waters (WAT) & Bruker (BRKR)
www.americanbankingnews.com - March 31 at 11:21 AM
Bruker (BRKR) Downgraded by Zacks Investment ResearchBruker (BRKR) Downgraded by Zacks Investment Research
www.americanbankingnews.com - March 30 at 9:28 PM
Bruker (BRKR) Lowered to Hold at Zacks Investment ResearchBruker (BRKR) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 29 at 9:36 PM
Bruker (BRKR) Rating Lowered to Buy at BidaskClubBruker (BRKR) Rating Lowered to Buy at BidaskClub
www.americanbankingnews.com - March 28 at 6:32 PM
Head to Head Analysis: Bruker (BRKR) vs. Allied Motion Technologies (AMOT)Head to Head Analysis: Bruker (BRKR) vs. Allied Motion Technologies (AMOT)
www.americanbankingnews.com - March 23 at 5:20 PM
Critical Contrast: Bruker (BRKR) versus Agilent Technologies (A)Critical Contrast: Bruker (BRKR) versus Agilent Technologies (A)
www.americanbankingnews.com - March 16 at 1:24 AM
Bruker Appoints Gerald Herman as Interim Chief Financial OfficerBruker Appoints Gerald Herman as Interim Chief Financial Officer
finance.yahoo.com - March 14 at 8:03 AM
Bruker names interim CFOBruker names interim CFO
seekingalpha.com - March 14 at 7:43 AM
Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five MinutesBruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes
finance.yahoo.com - March 12 at 6:55 PM
Bruker (BRKR) Down 9.3% Since Earnings Report: Can It Rebound?Bruker (BRKR) Down 9.3% Since Earnings Report: Can It Rebound?
finance.yahoo.com - March 12 at 7:13 AM
Bruker Co. (BRKR) Receives Consensus Recommendation of "Hold" from BrokeragesBruker Co. (BRKR) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - March 10 at 9:42 PM

SEC Filings

Bruker (NASDAQ:BRKR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bruker (NASDAQ:BRKR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bruker (NASDAQ BRKR) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.